1. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial. (September 2021) Authors: Gaur, Aditya H; Cotton, Mark F; Rodriguez, Carina A; McGrath, Eric J; Helström, Elizabeth; Liberty, Afaaf; Natukunda, Eva; Kosalaraksa, Pope; Chokephaibulkit, Kulkanya; Maxwell, Heather; Wong, Pamela; Porter, Danielle; Majeed, Sophia; Yue, Mun Sang; Graham, Hiba; Martin, Hal; Brainard, Diana M; P... Journal: Lancet Issue: Volume 5:Number 9(2021) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗